Mohammadi Seyed Mohammad, Saniee Nadia, Borzoo Tara, Radmanesh Esmat
Department of Orthopedics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Basic Science, Asadabad School of Medical Sciences, Asadabad, Iran.
Iran J Public Health. 2024 Jan;53(1):93-103. doi: 10.18502/ijph.v53i1.14686.
Leptin has a great effect on bone through direct or indirect involvement in bone remodeling. Considering the ambiguities that exist regarding the effect of leptin on bone and bone-related diseases including osteoporosis, in this study, we aimed to conduct a systematic review of various studies on the effect of leptin on osteoporosis, which may find an answer to the existing ambiguities.
The search was performed to review studies on the effects of leptin on osteoporosis by using several databases including Scopus, PubMed, Web of Science, and Google Scholar. Electronic searches were conducted on 5 Jan 2023. There was no limit on the publication date of the articles. The risk of bias for the animal study was assessed with the CAMARADES checklist, and the study quality assessment was also assessed based on the guidelines for in vivo experiments (ARRIVE). In this study, the risk of bias (quality) of human studies was assessed using the quality assessment checklists by NHLBI.
Overall, 34 articles were included for data extraction and quality assessment. Overall, 27 human studies and seven animal studies were included in the article. The results of most of the studies conducted in this study showed that leptin has a physiological role in maintaining bone mass and better bone quality and reduces bone marrow adipogenesis and increases bone mineral density (BMD). As plasma leptin levels increased, BMD values or bone formation biomarkers increased.
Leptin has an inhibitory role against bone resorption and increasing osteoprotegerin (OPG) levels, which, as a result, maintains bone density and reduces osteoclast activity, and has a positive relationship with increasing osteocalcin.
瘦素通过直接或间接参与骨重塑对骨骼产生重大影响。鉴于瘦素对骨骼及包括骨质疏松症在内的骨相关疾病的影响存在诸多不明确之处,在本研究中,我们旨在对关于瘦素对骨质疏松症影响的各类研究进行系统综述,以期找到解决现有不明确问题的答案。
通过使用包括Scopus、PubMed、科学网和谷歌学术在内的多个数据库,检索有关瘦素对骨质疏松症影响的研究。于2023年1月5日进行电子检索。对文章的发表日期没有限制。使用CAMARADES清单评估动物研究的偏倚风险,并根据体内实验指南(ARRIVE)评估研究质量。在本研究中,使用美国国立心肺血液研究所的质量评估清单评估人体研究的偏倚(质量)风险。
总体而言,纳入34篇文章进行数据提取和质量评估。文章共纳入27项人体研究和7项动物研究。本研究中开展的大多数研究结果表明,瘦素在维持骨量和改善骨质方面具有生理作用,可减少骨髓脂肪生成并增加骨密度(BMD)。随着血浆瘦素水平升高,BMD值或骨形成生物标志物增加。
瘦素对骨吸收具有抑制作用,并能提高骨保护素(OPG)水平,从而维持骨密度并降低破骨细胞活性,且与骨钙素增加呈正相关。